Benjamin Le Calvé

机构：Université de Lille, Io Therapeutics (United States) · ORCID：0009-0001-8745-1925

发表论文 70 篇 · 总被引 2118 次 · h-index 21

代表论文

• Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment (2024 · npj Aging · 被引 130)
• Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer (2023 · Cell Cycle · 被引 18)
• Abstract 2605: STX-1, a potent first-in-class ADC directed against DPP4 (CD26) as a biomarker of senescent tumor cells (2024 · Cancer Research · 被引 1)
• Abstract 6011: Treatment-induced senescence in metastatic colorectal adenocarcinomas: implications for single-cell biology and therapeutic intervention (2026 · Cancer Research)
• Abstract 1692: STX-1, a first-in-class ADC targeting DPP4 protein, acts as an anticancer and senolytic treatment (2026 · Cancer Research)
• 14P Dipeptidyl peptidase 4 (DPP4) as a new senescence-associated target to eliminate cancer cells (2025 · ESMO Open)